Cancer treatment techniques have significantly been advanced in recent decades, but they have a disadvantage of remarkably lowering the immune system in the body. To overcome this issue, immunotherapy is suggested to stimulate the immune system of hum...
Cancer treatment techniques have significantly been advanced in recent decades, but they have a disadvantage of remarkably lowering the immune system in the body. To overcome this issue, immunotherapy is suggested to stimulate the immune system of humans to increase the effectiveness of cancer treatment. Strategies of cancer immunotherapy include immune checkpoint therapy, adoptive cell transfer, and cancer vaccine therapy. Recently, Uric acid (UA), the metabolic end-product of purine metabolism in humans, has been used as an adjuvant in immunotherapy. The crystalline Uric acid (MSU), the leading cause of gout, is known as damage-associated molecular patterns (DAMPs), which are the starting point for triggering the immune effector including dendritic cells and macrophages. In this paper, I devised a photo-switching Nanogel cancer vaccine based on the crystallization of UA, which can be triggered by photodynamic therapy (PDT) via an on-off system for enhancing immune responses. MSU produced after PDT was confirmed using TEM, suggesting that crystallization of UA can be controlled through an on-off system by PDT. The cell penetration efficiency, intracellular distribution, and photo-induced cytotoxicity of the Nanogel were evaluated by in vitro studies on a cancer cell line. Further, the immunogenic efficacy was evaluated by quantitative analysis of DAMPs expression on a cancer cell line.